Articles in section Mergers & Acquisitions

<< Licensing

662 articles

Opinion & Analysis >>

<< Previous

Pages 1 ..2 3 4 5 6 7 .. 67

Next >>

AstraZeneca to Acquire LogicBio for US$68.2 M Published: 20 Oct-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 10
Genfit Buys Versantis to Rebuild its Liver Disease Portfolio Published: 21 Sep-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 9
Novo Nordisk to Acquire Forma Therapeutics for US$1.1 B Published: 13 Sep-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 9
Roche Acquires Good Therapeutics for US$250 M Upfront Published: 10 Sep-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 9
Alcon to Acquire Aerie Pharmaceuticals for US$770 M Published: 26 Aug-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 8
Ipsen Acquires Epizyme to Broaden its Oncology Portfolio Published: 14 Jul-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 7
Vertex Buys ViaCyte for Diabetes Stem Cell Treatment Published: 14 Jul-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 7
AstraZeneca Acquires TeneoTwo in US$1.27 B Deal Published: 7 Jul-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 7
Galapagos Acquires CellPoint and AboundBio for Next-Generation Cell Therapies Published: 5 Jul-2022
By: Swati Sharan
Abstract Fulltext:
Volume: 2022 Issue: 7
Bristol Myers Squibb Buys Turning Point for US$4.1 B Published: 8 Jun-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 6

Login

Username:

Password:

Keep me logged in